[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO6070080A1 - Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion - Google Patents

Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion

Info

Publication number
CO6070080A1
CO6070080A1 CO07048367A CO07048367A CO6070080A1 CO 6070080 A1 CO6070080 A1 CO 6070080A1 CO 07048367 A CO07048367 A CO 07048367A CO 07048367 A CO07048367 A CO 07048367A CO 6070080 A1 CO6070080 A1 CO 6070080A1
Authority
CO
Colombia
Prior art keywords
agent
pharmaceutical composition
solid pharmaceutical
procedure
preparation
Prior art date
Application number
CO07048367A
Other languages
English (en)
Inventor
Sierra Juan Jose Hernandez
Original Assignee
Diagnofast Ltda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnofast Ltda filed Critical Diagnofast Ltda
Priority to CO07048367A priority Critical patent/CO6070080A1/es
Priority to BRPI0811873-6A2A priority patent/BRPI0811873A2/pt
Priority to US12/600,225 priority patent/US20110039293A1/en
Priority to MX2009012437A priority patent/MX2009012437A/es
Priority to PCT/IB2008/001346 priority patent/WO2009016440A1/en
Priority to JP2010508000A priority patent/JP2011520767A/ja
Publication of CO6070080A1 publication Critical patent/CO6070080A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Composición farmacéutica sólida efervescente para la determinación cuantitativa de los niveles de azúcar y la capacidad del páncreas para eliminar azucares innecesarios, CARACTERIZADA porque comprende: (a) un agente rehidratante (b) un agente acidulante (c) un agente alcalinizante (d) un agente saborizante (e) un agente colorante.2 Proceso para preparar una composición farmacéutica sólida efervescente conforme cualquiera de las reivindicaciones anteriores, CARACTERIZADO porque comprende:(i) pulverización del agente acidulante,(ii) mezclado del agente rehidratante, el agente acidulante, el agente alcalanizante y el agente saborizante.(iii) secado de la mezcla del paso (ii) anterior.(iv) controlar el contenido de Humedad Relativa (%HR), envasar y empacar.
CO07048367A 2007-05-15 2007-05-15 Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion CO6070080A1 (es)

Priority Applications (6)

Application Number Priority Date Filing Date Title
CO07048367A CO6070080A1 (es) 2007-05-15 2007-05-15 Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion
BRPI0811873-6A2A BRPI0811873A2 (pt) 2007-05-15 2008-05-19 Composição farmacêutica sólida efervescente que contém dextrose e procedimento para sua preparação.
US12/600,225 US20110039293A1 (en) 2007-05-15 2008-05-19 Effervescent Solid Pharmaceutical Composition Comprising Dextrose and Process for its Preparation
MX2009012437A MX2009012437A (es) 2007-05-15 2008-05-19 Composicion farmaceutica sólida efervescente que contiene dextrosa y procedimiento para su preparacion.
PCT/IB2008/001346 WO2009016440A1 (en) 2007-05-15 2008-05-19 Effervescent solid pharmaceutical composition comprising dextrose and process for its preparation
JP2010508000A JP2011520767A (ja) 2007-05-15 2008-05-19 デキストロースを有する発泡性固形医薬組成物及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO07048367A CO6070080A1 (es) 2007-05-15 2007-05-15 Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion

Publications (1)

Publication Number Publication Date
CO6070080A1 true CO6070080A1 (es) 2009-08-31

Family

ID=40084120

Family Applications (1)

Application Number Title Priority Date Filing Date
CO07048367A CO6070080A1 (es) 2007-05-15 2007-05-15 Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion

Country Status (6)

Country Link
US (1) US20110039293A1 (es)
JP (1) JP2011520767A (es)
BR (1) BRPI0811873A2 (es)
CO (1) CO6070080A1 (es)
MX (1) MX2009012437A (es)
WO (1) WO2009016440A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2706727C2 (ru) 2014-09-17 2019-11-20 Стирлайф Индия Прайвит Лимитед Шипучие композиции и способы их получения и применения
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04327526A (ja) * 1991-04-26 1992-11-17 Lion Corp 経口用固形製剤
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
JP3490455B2 (ja) * 1995-06-30 2004-01-26 シープロ インコーポレイティド 固形経口診断用試験食及びその利用方法
EP0872544A1 (en) * 1997-04-14 1998-10-21 The Procter & Gamble Company Dry effervescent granules and granular compositions comprising the same
EP1771081A4 (en) * 2003-12-15 2007-11-14 Smithkline Beecham Corp CLEANING COMPOSITIONS WITH SENSOR SIGNAL
WO2006044595A2 (en) * 2004-10-13 2006-04-27 Cadbury Adams Usa Llc Effervescent pressed gum tablet compositions
US8956652B2 (en) * 2005-09-15 2015-02-17 Tower Laboratories, Ltd. Effervescent rehydrating beverage tablet/granules
WO2008025468A1 (en) * 2006-08-31 2008-03-06 Dsm Ip Assets B.V. Oral care effervescent composition

Also Published As

Publication number Publication date
BRPI0811873A2 (pt) 2014-11-18
US20110039293A1 (en) 2011-02-17
MX2009012437A (es) 2010-08-09
WO2009016440A1 (en) 2009-02-05
JP2011520767A (ja) 2011-07-21

Similar Documents

Publication Publication Date Title
Zhang et al. Evaluation of the cellular and animal models for the study of antioxidant activity: a review
NO20064584L (no) Tetrahydropyridoindolderivater
NO20073059L (no) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
CR9292A (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
MX2009012000A (es) Derivados de pirazol heteroarilo sustituidos utiles para el tratamiento de trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis.
CO6210803A2 (es) Formulaciones liquidas formadoras de pelicula dermica para la liberacion de farmaco a la piel
WO2007121352A3 (en) Therapeutic triterpenoids
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
BR112017026287A2 (pt) composições de hidroxipropil beta-ciclodextrina e métodos
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
NO20092473L (no) Kombinasjon
UY37823A (es) Composiciones edulcorantes y de enmascaramiento del gusto, productos y usos de las mismas
AR114550A1 (es) Moléculas de unión al antígeno anti-cd137 y sus usos
CO6070080A1 (es) Composicion farmaceutica solida efervescente que contiene dextrosa y procedimiento para su preparacion
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
Martín et al. Cocoa flavanols show beneficial effects in cultured pancreatic beta cells and liver cells to prevent the onset of type 2 diabetes
AR075041A1 (es) Composicion farmaceutica que contiene aleglitazar, proceso, uso.
BR112013002832A2 (pt) composição compreendendo retinol, um precursor ou um produto de reação do mesmo e um extrato vegetal de pelo menos uma planta de camomila para o tratamento de câncer
AR094770A1 (es) Composición masticable para administración oral y proceso para preparar la misma
MX2009010582A (es) Procedimiento de tratamiento nematocida de las plantas a base de eugenol y de lecitina(s) y/o derivados.
AR095445A1 (es) Sustancias bioactivas estables y métodos de preparación
NO20073046L (no) Utvalgte benzofuranderivater
WO2021213931A1 (fr) Nouvel inhibiteur non protéique de furine

Legal Events

Date Code Title Description
FC Application refused